Ultragenyx Pharmaceutical

+$0.58 (+0.97%) Today
$0.00 (0.00%) As of 8:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, engaged in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its products include Mepsevii and Crysvita.

CEO
Emil D. Kakkis
Employees
1,119
Headquarters
Novato, California
Founded
2010

RARE Key Statistics

Market cap
4.24B
Price-Earnings ratio
—
Dividend yield
—
Average volume
586.49K
High today
$60.69
Low today
$57.26
Open price
$60.69
Volume
646.27K
52 Week high
$104.38
52 Week low
$45.20

RARE News

Simply Wall StJun 23

For Ultragenyx Pharmaceutical Inc. insiders, selling US$3.0m worth of stock earlier this year was a smart move. - Simply Wall St

Despite the fact that Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stock rose 11% last week, insiders who sold US$3.0m worth of stock in the previous 12 months

RARE Earnings

-$2.19
-$1.46
-$0.73
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure